Navigation Links
News from the American Heart Association
Date:12/10/2007

g with further clarification and updates on other drug treatments, such as intravenous beta blocker therapy, and new recommendations about new drug treatments that should be used in patients with STEMI," Antman said.

NSAIDs have been linked to an increased risk of adverse effects in people with heart disease or heart disease risk factors. Because of this risk, the American Heart Association in February 2007 advised physicians to change the way they prescribe pain relievers, using COX-2 inhibitors and NSAIDs as the last line of treatment, instead of as a first line treatment.

The update now says to stop NSAIDs and COX-2 inhibitors during the acute phase of treatment in patients with STEMI. After the initial treatment, there are recommendations for a "rigorous review of any ongoing needs for pain control at the time of hospital discharge, followed by a five-step process for choosing appropriate pain medicines," Antman said. In all cases, the lowest effective doses should be used for the shortest possible time and COX-2 selective NSAIDs should be considered only as a last resort.


'/>"/>
SOURCE American Heart Association; American College of Cardiology
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
2. Lexicon to Present Research Results at American Chemical Society Meeting Regarding Target of LX1031 Drug Candidate
3. GlaxoSmithKline Receives New HHS Order for H5N1 Bulk Antigen. First North American Clinical Trials with GSKs Candidate Pre-pandemic Flu Vaccine to Start.
4. Aspirin Named 8th World Wonder by Majority of Americans
5. MedImmunes Motavizumab Reduced RSV Hospitalizations by 83 Percent Among High-Risk Native American, Full-Term Infants in Placebo-Controlled Phase 3 study
6. American Heart Association Comment Saving Lives in Type 2 Diabetics: Could It Be as Easy as Lowering Blood Pressure?
7. TrialCheck(R) Cancer Clinical Trial Matching Interface to Debut on American Cancer Society Web Site
8. Hypertension: Journal of the American Heart Association Rapid Access Reports: Hispanics Hypertension Better Controlled With Equal Access to Care
9. Positive Results for NKTR-118 (oral PEG-naloxol) Presented at American Academy of Pain Management Meeting
10. Preimplantation Genetic Diagnosis International Society Refutes American Society of Reproductive Medicine Opinion - States Preimplantation Genetic Screening is Beneficial When Performed in Experienced Centers
11. New MIRCERA(R) Data Analyses to be Featured at the American Society of Nephrology Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/31/2015)... 31, 2015  Asterias Biotherapeutics, Inc. (NYSE MKT: ... field of regenerative medicine, today announced that the ... Chicago -based Rush University Medical Center in ... escalating doses of AST-OPC1 (oligodendrocyte progenitor cells) in ... cervical spinal cord injury (SCI). This represents the ...
(Date:8/31/2015)... 2015   BioLife Solutions , Inc. (NASDAQ: ... marketer of proprietary clinical grade cell and tissue ... media and a related cloud hosted ... smart shippers ("BioLife" or the "Company"), today ... biopharmaceutical company focused on developing and commercializing novel ...
(Date:8/28/2015)... , Aug. 28, 2015  With the heroin ... reaching deadlier heights, Jacksonville -based Lakeview ... Hemphill is helping to explain why fentanyl is ... approximately 40 to 50 times more potent than pharmaceutical ... users as heroin, the risk of death skyrockets. ...
Breaking Medicine Technology:Asterias Biotherapeutics Concludes Recruitment of Initial Safety Cohort of the SCiStar Phase 1/2a Dose-Escalation Clinical Trial of AST-OPC1 for Complete Cervical Spinal Cord Injury 2Asterias Biotherapeutics Concludes Recruitment of Initial Safety Cohort of the SCiStar Phase 1/2a Dose-Escalation Clinical Trial of AST-OPC1 for Complete Cervical Spinal Cord Injury 3Asterias Biotherapeutics Concludes Recruitment of Initial Safety Cohort of the SCiStar Phase 1/2a Dose-Escalation Clinical Trial of AST-OPC1 for Complete Cervical Spinal Cord Injury 4Asterias Biotherapeutics Concludes Recruitment of Initial Safety Cohort of the SCiStar Phase 1/2a Dose-Escalation Clinical Trial of AST-OPC1 for Complete Cervical Spinal Cord Injury 5Asterias Biotherapeutics Concludes Recruitment of Initial Safety Cohort of the SCiStar Phase 1/2a Dose-Escalation Clinical Trial of AST-OPC1 for Complete Cervical Spinal Cord Injury 6BioLife Solutions Customer TiGenix Phase 3 Clinical Trial Meets Primary Endpoint 2BioLife Solutions Customer TiGenix Phase 3 Clinical Trial Meets Primary Endpoint 3BioLife Solutions Customer TiGenix Phase 3 Clinical Trial Meets Primary Endpoint 4BioLife Solutions Customer TiGenix Phase 3 Clinical Trial Meets Primary Endpoint 5Lakeview Health's Dr. Philip Hemphill Explains Why Heroin Addicts Are Now Dying of Fentanyl Overdoses 2
... (OTCQX: DATA), a technology and services company focused on global ... its Vice President of Research and Development, Chris Wilke, has ... 2009 Society for Clinical Data Management (SCDM) Annual Conference which ... Mr. Wilke will be discussing Is 100% EDC Realistic? ...
... ThermalTherapeutic Systems, Inc., developers of a highly ... today the completion of $2.75 Million Series A ... funding by the Pittsburgh Life Sciences Greenhouse, and ... investments by the Pittsburgh Life Sciences Greenhouse and ...
Cached Medicine Technology:DATATRAK to Present at 2009 SCDM Annual Conference 2DATATRAK to Present at 2009 SCDM Annual Conference 3ThermalTherapeutic Systems Completes $2.75 Million Series A Financing With Originate Ventures 2
(Date:8/31/2015)... ... August 31, 2015 , ... Cosmetic Town Journal is an ... to have a successful cosmetic procedure; from publishing encyclopedic medical articles to inform ... always ready to help. , It is clear that the Cosmetic Town aesthetic ...
(Date:8/31/2015)... ... August 31, 2015 , ... Dental clinicians from Newcastle University, ... Sciences to learn more about its integrated approach to diabetes care. , Philip ... of Cellular Medicine at Newcastle University, and Susan Bissett, National Institute for Health ...
(Date:8/31/2015)... Angeles, CA (PRWEB) , ... August 31, 2015 , ... When it comes to undergoing ... to the top of the head. Adding more volume to the hair on top ... procedure for patients who have a good amount of donor hair on other areas of ...
(Date:8/31/2015)... (PRWEB) , ... August 31, 2015 , ... ... insurance, announced today their new “ InstantQuote ” tool, which summarizes all available ... easy-to-understand format. The technology tool is designed to help India Network members make ...
(Date:8/31/2015)... ... , ... The Lisle family law firm of Momkus McCluskey, LLC ... peers to earn a “Leading Lawyers” distinction. , The “Leading Lawyers” ... Illinois. The nomination process is based on statewide peer survey nominations and the approval ...
Breaking Medicine News(10 mins):Health News:Cosmetic Town: A One Stop Plastic Surgery Community 2Health News:Western Diabetes Institute Collaborates with UK team 2Health News:Western Diabetes Institute Collaborates with UK team 3Health News:Western Diabetes Institute Collaborates with UK team 4Health News:Body Hair Transplants to Help Achieve a Full Head of Hair 2Health News:India Network proudly launches the new InstantQuote tool to help choose right visitor health insurance with pre-existing conditions to US bound visitors 2Health News:DuPage County Family Law Attorney Named Illinois Leading Lawyer 2
... possible in an effort to reverse its progression.Arthritis affects ... of disability in people over the age of 15, ... able to treat the disease and offer tips to ... genetic signs that indicate the early onset of arthritis. ...
... Orchid Chemicals & Pharmaceuticals Ltd today said it has ... New Drug Application) of Cephalexin oral suspension. // ... Chemicals' distribution alliance with US generic pharma major Par ... ,Orchid added that its Cephalexin capsules are already marketed ...
... the treatment of a 14-month-old Malaysian Indian baby who is suffering ... at the University Malaya Medical Centre, is suffering from the rare ... condition that is present at birth marked by a very small ... and there is cleft soft palate. ,Sreeram can ...
... conducted by Dr. Mark B. Landon of Ohio State University ... that it was not risky// to attempt vaginal delivery for ... ,The study results were published in the journal Obstetrics and ... for women who have had several previous cesarean deliveries to ...
... women with breast cancer have warned others to be wary ... been given a clean diagnosis in spite of having cancer.// ... Phillipa Naismith, 52, and Sandra Harley, 48, explained that they ... all clear by BreastScreen Queensland. They have now hired one ...
... a law that would protect HIV/AIDS patient's rights to privacy, ... for a woman with the right to seek an HIV ... is supposedly the country with the highest number of HIV/AIDS ... bill is being proposed to control this problem at the ...
Cached Medicine News:Health News:Researchers Beginning to Identify Genetic Culprits of Arthritis 2Health News:BreastScreen Australia Is Being Sued Towards Medical Negligence 2Health News:New Law On HIV/AIDS To Be Implemented At The Monsoon Session Of Parliament 2
The Natural Selection family of specialty allografts is spinal concepts response to surgeon requests for spinal allograft devices to eliminate the need for painful autograft harvesting....
Transcranial vascular DWL doppler....
Transcranial vascular DWL doppler....
... Neurocare is a full-featured physiologic testing system offered ... contains many of the features of our flagship ... economical price. , ,The smaller size of the ... environment, the physician's office, a mobile service or ...
Medicine Products: